Health Economics Thesis Topics

Health economics thesis topics represent one of the most analytically rigorous and policy-relevant areas within health thesis topics, drawing graduate students at American universities into a discipline that applies economic theory and quantitative methods to understand how healthcare resources are allocated, how health markets function, and how policy interventions shape the cost, quality, and equity of healthcare systems. Health economics encompasses health insurance markets, provider payment reform, pharmaceutical pricing, cost-effectiveness analysis, the economics of health behaviors, and the distributional consequences of healthcare financing — all of which are subjects of intense policy debate in the United States. As American healthcare spending approaches one-fifth of gross domestic product while significant portions of the population remain underinsured or face catastrophic out-of-pocket costs, the research questions animating health economics thesis topics have never carried greater real-world stakes.

Health Economics Thesis Topics and Research Areas

The discipline of health economics draws on microeconomic theory, econometrics, decision science, and public finance to analyze markets and behaviors that are shaped by profound information asymmetries, externalities, moral hazard, and the ethical dimensions of healthcare as both a commodity and a human right. Graduate students pursuing health economics thesis topics engage with causal inference methods including instrumental variables, difference-in-differences, and regression discontinuity designs that allow credible conclusions to be drawn from observational data — essential in a field where randomized experiments are often infeasible. The 200 health economics thesis topics below are organized into 10 thematic categories, each representing an active area of investigation at American schools of public health, economics departments, and policy research institutions.

1. Health Insurance Markets and Coverage

Health insurance is the primary mechanism through which Americans access and finance healthcare, making insurance market structure, coverage design, and enrollment behavior a foundational category of health economics thesis topics. Research here addresses the Affordable Care Act’s market reforms, Medicaid expansion, employer-sponsored insurance, premium sensitivity, adverse selection, and the equity consequences of coverage gaps. Graduate students at American universities contribute rigorous evaluations of insurance policy that inform ongoing legislative and regulatory debates about how best to achieve universal, affordable, and meaningful coverage across the American population.

1. Investigating the effect of Affordable Care Act Medicaid expansion on coverage rates, healthcare utilization, and financial protection among low-income adults in expansion versus non-expansion states using difference-in-differences methodology
2. Analyzing the adverse selection dynamics in Affordable Care Act marketplace plans and their relationship to premium growth and plan exit decisions by insurers across American rating regions
3. Developing a microsimulation model for projecting the coverage and expenditure effects of a public option health insurance plan on American employer-sponsored and marketplace insurance markets
4. Characterizing the relationship between high-deductible health plan enrollment and delayed or foregone care among American adults with chronic conditions using nationally representative survey data
5. Investigating the premium elasticity of demand for health insurance among self-employed American adults using variation in state-level marketplace premium tax credit generosity as a natural experiment
6. Analyzing the impact of short-term limited duration health plan availability on Affordable Care Act marketplace enrollment and risk pool composition in American states with permissive regulations
7. Developing a framework for evaluating the adequacy of health insurance plan networks for specialty care access across American metropolitan and rural marketplace plan offerings
8. Characterizing the Medicaid churning phenomenon — repeated coverage gains and losses — and its consequences for care continuity and chronic disease management among low-income American adults
9. Investigating the effect of auto-enrollment policies on Medicaid and marketplace plan take-up rates among eligible but unenrolled American adults using state policy variation as a quasi-experiment
10. Analyzing the relationship between health insurance literacy and plan selection quality among American marketplace consumers using the Medical Expenditure Panel Survey and plan characteristic data
11. Developing a welfare analysis framework for evaluating the distributional consequences of eliminating the individual mandate penalty on American health insurance market stability and enrollment equity
12. Characterizing the employer-sponsored insurance offer rates and coverage take-up decisions of American small business employees across industry sector, wage level, and firm size categories
13. Investigating the spillover effects of Medicaid expansion on previously insured populations’ premium levels and plan choices in American individual insurance markets
14. Analyzing the geographic variation in health insurance coverage gaps among American adults between Medicaid income eligibility thresholds and marketplace subsidy eligibility across non-expansion states
15. Developing a cost-benefit analysis of continuous Medicaid enrollment policies for children in American states and evaluating their effects on preventive care utilization and developmental health outcomes
16. Characterizing the mental health coverage parity compliance patterns of American commercial insurers and their relationship to behavioral health service utilization and out-of-pocket costs
17. Investigating the impact of cost-sharing reduction subsidy elimination on silver plan enrollment, premium-loading, and Medicaid enrollment in American marketplace counties
18. Analyzing the health and financial consequences of coverage loss following Medicaid disenrollment in American states implementing work requirement policies using interrupted time series methodology
19. Developing an actuarial risk adjustment model improvement framework for American marketplace plans that better accounts for behavioral health and social risk factors in premium setting
20. Characterizing the relationship between insurance coverage generosity measured by actuarial value and preventive service utilization rates among American adults with employer-sponsored insurance

2. Healthcare Provider Payment and Delivery Reform

Payment reform sits at the center of American health policy efforts to improve value in healthcare, making this a particularly active category of health economics thesis topics at health policy schools and economics departments nationwide. Research here addresses fee-for-service incentives, bundled payments, capitation, accountable care organizations, pay-for-performance programs, and the behavioral responses of hospitals, physicians, and health systems to alternative payment models. Graduate students contribute rigorous evaluations of payment reform using administrative claims data, Medicare program data, and natural experiments created by the staggered rollout of payment innovations across American healthcare markets.

21. Investigating the effect of Medicare Shared Savings Program accountable care organization participation on total Medicare spending, quality performance, and care utilization patterns using difference-in-differences analysis
22. Analyzing the impact of the Comprehensive Care for Joint Replacement bundled payment model on episode costs, complication rates, and post-acute care utilization in American orthopedic practices
23. Developing a theoretical model of physician behavioral response to value-based payment incentives under conditions of incomplete information and multitasking across quality and cost dimensions
24. Characterizing the selection patterns into Medicare accountable care organization contracts by American physician groups and hospital systems with different baseline cost and quality profiles
25. Investigating the spillover effects of Medicare bundled payment participation on commercially insured patients receiving care from participating American hospital and physician organizations
26. Analyzing the impact of hospital readmission reduction program financial penalties on thirty-day readmission rates and post-discharge care coordination practices in American safety-net hospitals
27. Developing a difference-in-differences evaluation of direct contracting entity payment model effects on primary care transformation and total cost of care in American Medicare beneficiary populations
28. Characterizing the physician compensation model structures within American multispecialty group practices and their relationship to productivity, quality performance, and physician satisfaction
29. Investigating the effect of Medicaid managed care capitation rate adequacy on network participation rates and access to specialty care for American Medicaid beneficiaries with complex needs
30. Analyzing the relationship between hospital market concentration and negotiated private insurance reimbursement rates across American metropolitan statistical areas using all-payer claims data
31. Developing a cost-effectiveness evaluation of the Centers for Medicare and Medicaid Innovation Comprehensive Primary Care Plus model for transforming primary care in American fee-for-service markets
32. Characterizing the upcoding and diagnostic intensity changes in American physician practices following transition from fee-for-service to Medicare Advantage risk-adjusted capitation payment
33. Investigating the impact of global budget payment models on hospital capacity utilization, service line mix decisions, and safety-net mission preservation in American rural hospital markets
34. Analyzing the relationship between physician group consolidation into hospital employment and the intensity and cost of care delivered to commercially insured patients in American metropolitan markets
35. Developing a structural econometric model of hospital service line profitability calculations and their influence on capital investment and program development decisions in American competitive markets
36. Characterizing the care coordination investments and infrastructure development patterns of American accountable care organizations achieving shared savings compared to those that do not
37. Investigating the moral hazard implications of zero-dollar copayment primary care models in American direct primary care and concierge medicine practices on total healthcare expenditure
38. Analyzing the quality measurement burden and administrative cost of pay-for-performance program participation for small and independent American physician practices
39. Developing a payment adequacy assessment framework for evaluating Medicaid fee schedules for primary care, behavioral health, and obstetric services across American states
40. Characterizing the financial risk distribution between payers, providers, and patients under alternative payment model designs and its relationship to care transformation investment decisions

3. Pharmaceutical Economics and Drug Pricing

The economics of pharmaceutical markets — including drug pricing, patent policy, generic entry, formulary design, and the incentives governing innovation investment — represents one of the most politically contentious and analytically complex categories of health economics thesis topics, particularly as American drug prices remain dramatically higher than those in peer nations and spending on specialty biologics continues to grow rapidly. Graduate students contribute economic analyses of patent exclusivity, reference pricing policies, pharmacy benefit manager practices, and biosimilar competition that directly inform the policy debates shaping American drug spending and access.

41. Investigating the effect of Medicare Part D low-income subsidy eligibility on prescription drug adherence and health outcomes among American adults with diabetes and cardiovascular disease
42. Analyzing the relationship between pharmacy benefit manager formulary design and brand versus generic drug utilization rates in American commercial insurance plan populations
43. Developing a dynamic model of pharmaceutical firm pricing strategy under Medicare drug price negotiation authority established by the Inflation Reduction Act and its implications for launch prices
44. Characterizing the biosimilar market penetration barriers in American specialty pharmacy markets and their relationship to originator biologic rebate contracting practices with pharmacy benefit managers
45. Investigating the impact of step therapy and prior authorization requirements on specialty medication access delays and health outcomes in American patients with autoimmune and oncologic conditions
46. Analyzing the relationship between patent thicket density — the accumulation of secondary patents — and delayed generic entry timing for top-selling American brand-name pharmaceutical products
47. Developing a cost-effectiveness threshold framework calibrated to American willingness-to-pay estimates for use in Medicare coverage and reimbursement decision-making for novel therapeutics
48. Characterizing the drug affordability consequences of high-deductible health plan cost-sharing structures for American patients requiring specialty medications for chronic conditions
49. Investigating the price and utilization effects of international reference pricing policies applied to Medicare Part B physician-administered drugs using simulation modeling of policy scenarios
50. Analyzing the orphan drug designation program’s influence on research investment allocation and pricing behavior for rare disease therapeutics marketed in the United States
51. Developing a market competition analysis framework for evaluating the adequacy of biosimilar market structure in American biologic drug classes following regulatory approval of multiple entrants
52. Characterizing the out-of-pocket cost burden of cancer drug treatment on American patients and the relationship between cost-related nonadherence and treatment outcome disparities by income level
53. Investigating the impact of state pharmaceutical price transparency laws on drug pricing behavior and list price growth rates for brand-name medications sold in American markets
54. Analyzing the pharmacy benefit manager spread pricing practices in American Medicaid managed care programs and their implications for drug expenditure and pharmacist reimbursement adequacy
55. Developing an economic model of antibiotic innovation incentive reform that addresses the market failure in antimicrobial drug development while maintaining appropriate stewardship in American healthcare settings
56. Characterizing the price differential between American pharmaceutical list prices and net prices after rebates across therapeutic classes and its implications for patient cost-sharing design
57. Investigating the effect of Medicare Part D coverage gap elimination under the Inflation Reduction Act on medication adherence and health outcomes for American beneficiaries with high drug costs
58. Analyzing the generic drug market concentration and price volatility patterns for essential medications in American hospital and community pharmacy supply chains
59. Developing a welfare analysis of compulsory licensing as a policy tool for improving access to high-priced essential medicines in the American market for uninsured and underinsured patients
60. Characterizing the relationship between pharmaceutical company marketing expenditure allocation between consumer advertising and physician detailing and prescribing behavior patterns in American clinical practice

4. Cost-Effectiveness Analysis and Health Technology Assessment

Cost-effectiveness analysis and health technology assessment provide the analytical foundations for evidence-based resource allocation decisions in healthcare — determining which interventions deliver sufficient health benefit relative to their costs to warrant coverage, reimbursement, and implementation. This category of health economics thesis topics is methodologically rigorous, drawing on decision modeling, quality-adjusted life year estimation, and health utility measurement to inform American payer, provider, and policy decisions. Graduate students contribute methodological advances in modeling approaches, health state utility estimation, and equity-weighted cost-effectiveness analysis that shape how American institutions evaluate new drugs, devices, diagnostics, and care delivery innovations.

61. Investigating the cost-effectiveness of universal colorectal cancer screening beginning at age forty-five versus forty-five for average-risk American adults using Markov model simulation methodology
62. Analyzing the value of information for key uncertain parameters in cost-effectiveness models of novel Alzheimer’s disease disease-modifying therapies for American Medicare coverage decision-making
63. Developing an equity-weighted cost-effectiveness analysis framework that incorporates health disparities considerations into coverage recommendation thresholds for American payer decision-making
64. Characterizing the health state utility value estimation methodologies used in published cost-effectiveness analyses of cardiovascular interventions and their influence on cost-per-QALY estimates
65. Investigating the cost-effectiveness of GLP-1 receptor agonist therapy for obesity management in American adults with type 2 diabetes across different payer and healthcare system perspectives
66. Analyzing the budget impact and cost-effectiveness of universal maternal depression screening programs integrated into American obstetric and pediatric primary care settings
67. Developing a cost-utility analysis of telehealth versus in-person delivery of cognitive behavioral therapy for depression in American rural primary care populations lacking mental health specialist access
68. Characterizing the cost-effectiveness evidence base for precision medicine diagnostic testing in American oncology practice and its alignment with payer coverage decision frameworks
69. Investigating the cost-effectiveness of pharmacogenomic testing-guided antidepressant prescribing compared to trial-and-error prescribing for American adults with major depressive disorder
70. Analyzing the methodological quality and reporting standards of cost-effectiveness analyses submitted to American commercial payers for novel specialty drug coverage decisions
71. Developing a decision analytic model evaluating the cost-effectiveness of universal newborn genomic sequencing programs in American neonatal settings for identifying actionable genetic conditions
72. Characterizing the societal cost-of-illness burden of type 2 diabetes and its complications in the American population using prevalence-based costing with national healthcare expenditure data
73. Investigating the cost-effectiveness of community health worker interventions for hypertension management in American underserved urban populations compared to standard primary care approaches
74. Analyzing the real-world cost and health outcome divergences from randomized trial assumptions in published cost-effectiveness models of novel oncology immunotherapy agents in American practice
75. Developing a comparative effectiveness and cost analysis of surgical versus conservative management for lumbar disc herniation in American working-age adults using instrumental variable methodology
76. Characterizing the cost-effectiveness of childhood obesity prevention interventions delivered through American school, primary care, and community settings using lifetime microsimulation modeling
77. Investigating the incremental cost-effectiveness of adding continuous glucose monitoring to insulin therapy for American adults with type 2 diabetes using real-world evidence and modeling approaches
78. Analyzing the cost-effectiveness threshold variation across American private and public payers and its implications for coverage decision consistency and patient access equity
79. Developing a cost-effectiveness analysis of universal hepatitis C virus screening and treatment programs in American primary care settings compared to risk-based screening approaches
80. Characterizing the multi-criteria decision analysis frameworks used by American health technology assessment bodies to incorporate non-cost-effectiveness factors including equity and unmet need into coverage recommendations

5. Health Behaviors and the Economics of Prevention

The economics of health behaviors — including the decisions individuals make about diet, physical activity, smoking, alcohol consumption, substance use, and preventive care utilization — represents an intellectually rich category of health economics thesis topics that connects behavioral economics, public health, and policy analysis. Research here investigates how prices, taxes, information, behavioral nudges, and social incentives shape health-related choices, and how employer wellness programs, public health campaigns, and regulatory policies can shift behavior at population scale. Graduate students at American universities contribute evidence on the effectiveness and cost-effectiveness of behavioral interventions that inform policy decisions affecting millions of Americans.

81. Investigating the price elasticity of demand for sugar-sweetened beverages among American adults across income levels using variation in city-level beverage tax rates as a natural experiment
82. Analyzing the effect of tobacco excise tax increases on smoking cessation rates and cigarette consumption among American adults stratified by income level and nicotine dependence severity
83. Developing a behavioral economic framework for evaluating the effectiveness of default enrollment designs in American employer wellness program participation and health behavior change outcomes
84. Characterizing the relationship between food environment quality measured by grocery store access and density and dietary quality and obesity rates in American urban and rural communities
85. Investigating the causal effect of minimum wage increases on health behaviors including smoking, alcohol consumption, and preventive care utilization among low-wage American workers
86. Analyzing the demand response of American adults to varying cost-sharing levels for preventive services under Affordable Care Act first-dollar coverage mandates using natural experiment methodology
87. Developing a financial incentive program design framework for promoting smoking cessation in American Medicaid populations and evaluating its cost-effectiveness compared to pharmacotherapy alone
88. Characterizing the social multiplier effects of physical activity behavior in American residential communities using peer effects estimation methodology in longitudinal health behavior survey data
89. Investigating the impact of front-of-package nutrition labeling requirements on food product reformulation and consumer purchase decisions in American grocery retail markets
90. Analyzing the demand for opioid analgesics in American markets following state prescription drug monitoring program implementation using difference-in-differences methodology
91. Developing an economic model of vaccine hesitancy that incorporates social learning, risk perception biases, and network effects to evaluate information intervention effectiveness in American communities
92. Characterizing the causal relationship between food assistance program participation through SNAP and dietary quality, obesity rates, and diabetes incidence among low-income American adults
93. Investigating the effect of calorie labeling mandates at American chain restaurants on meal calorie selection and dietary intake across income and education groups using quasi-experimental design
94. Analyzing the long-term return on investment of workplace wellness programs in American large employers using difference-in-differences evaluation of health claims and productivity outcomes
95. Developing a cost-benefit analysis of early childhood home visiting programs for improving maternal and child health behaviors and reducing long-term healthcare expenditure in American at-risk populations
96. Characterizing the demand responses to e-cigarette taxation across American states and their relationship to combustible cigarette use — examining substitution versus complementarity patterns
97. Investigating the effect of naloxone access law expansion on opioid overdose mortality rates in American states using staggered policy adoption as a natural experiment
98. Analyzing the behavioral and economic consequences of medical marijuana legalization on opioid prescribing, opioid mortality, and healthcare utilization in American states
99. Developing an economic evaluation of community-based diabetes prevention program delivery models in American federally qualified health center settings for Medicaid and uninsured populations
100. Characterizing the relationship between social isolation, loneliness, and healthcare expenditure in American Medicare beneficiaries using longitudinal claims and survey data linkage

6. Hospital Economics and Market Structure

Hospital markets in the United States have undergone dramatic consolidation over the past two decades, with profound implications for price competition, care quality, physician independence, and healthcare equity — making hospital economics and market structure a central and contested category of health economics thesis topics. Research here employs industrial organization methods to analyze merger effects, price negotiation, hospital competition, nonprofit versus for-profit behavior, and the relationship between market power and patient outcomes. Graduate students contribute antitrust economics analyses, price transparency research, and market structure studies that directly inform Federal Trade Commission enforcement, state certificate of need policies, and hospital payment reform.

101. Investigating the effect of hospital mergers on commercial insurance negotiated prices and quality of care outcomes in American metropolitan hospital markets using difference-in-differences methodology
102. Analyzing the relationship between hospital market concentration measured by Herfindahl-Hirschman Index and commercial insurance premium growth rates across American metropolitan statistical areas
103. Developing a price transparency compliance assessment for American hospital chargemaster and negotiated rate disclosure under federal transparency rules and evaluating consumer usability
104. Characterizing the nonprofit hospital community benefit expenditure patterns across American states and their relationship to charity care provision, tax exemption value, and community health improvement investment
105. Investigating the impact of Federal Trade Commission hospital merger challenges on transaction rates, proposed deal structures, and price outcomes in American hospital markets
106. Analyzing the relationship between critical access hospital designation and financial sustainability, service availability, and patient outcomes in rural American communities
107. Developing a structural model of hospital-insurer bargaining that incorporates quality competition, geographic market definition, and out-of-network billing practices in American hospital markets
108. Characterizing the for-profit hospital chain acquisition effects on charity care provision, staffing ratios, and clinical quality metrics in American community hospitals
109. Investigating the effect of certificate of need law repeal on hospital capacity, service line competition, and healthcare costs in American states that have eliminated these regulations
110. Analyzing the relationship between hospital vertical integration with physician practices and total episode-of-care costs for common surgical procedures in American commercial insurance markets
111. Developing a competitive effects analysis methodology for evaluating proposed cross-market hospital mergers involving health systems operating in geographically separate American markets
112. Characterizing the financial distress predictors and closure risk factors for American rural hospitals and evaluating state and federal rural hospital support program effectiveness
113. Investigating the price and volume effects of surprise billing prohibition under the No Surprises Act on American emergency and ancillary care markets using pre- and post-implementation claims analysis
114. Analyzing the relationship between hospital nursing staff ratios and both patient safety outcomes and hospital financial performance in American acute care settings
115. Developing an economic model of hospital disproportionate share hospital payment adequacy for supporting safety-net mission in American urban and rural uncompensated care settings
116. Characterizing the market entry and exit dynamics of ambulatory surgery centers in American metropolitan markets and their competitive effects on hospital outpatient surgery volumes and prices
117. Investigating the cross-subsidization patterns between profitable and unprofitable service lines in American nonprofit hospital systems and their implications for mission sustainability
118. Analyzing the relationship between health system executive compensation structures and value-based care performance, community benefit investment, and quality improvement outcomes
119. Developing a financial impact model for evaluating global budget payment policy effects on American rural hospital service line viability and community health service availability
120. Characterizing the price and quality competition dynamics in American urgent care and retail clinic markets and their effects on emergency department utilization and primary care access

7. Equity and Social Determinants in Health Economics

Health economics increasingly recognizes that market forces alone cannot explain health disparities, and that the economic analysis of healthcare must grapple with the structural determinants — income, wealth, race, geography, and education — that shape both health and healthcare access across American populations. This category of health economics thesis topics applies econometric and policy analysis methods to understand how poverty, discrimination, residential segregation, and social policy interact with healthcare markets to produce inequitable health outcomes. Graduate students contribute distributional analyses, natural experiment evaluations of social policy, and theoretical frameworks that advance health economics beyond efficiency concerns toward explicit equity considerations.

121. Investigating the causal effect of childhood poverty on adult healthcare utilization, chronic disease burden, and healthcare expenditure using instrumental variable approaches in American longitudinal survey data
122. Analyzing the relationship between residential racial segregation and hospital quality, access to specialty care, and preventable hospitalization rates in American metropolitan areas
123. Developing an economic framework for valuing health equity improvements alongside efficiency gains in American healthcare payment reform and technology assessment decision-making
124. Characterizing the health and economic consequences of medical debt burden on American households using bankruptcy filing data, credit record linkage, and health survey data
125. Investigating the causal effect of eviction on healthcare utilization, mental health outcomes, and chronic disease management in American urban populations using quasi-experimental methodology
126. Analyzing the distributional health and financial protection consequences of different universal health coverage financing mechanisms — payroll tax, income tax, and premium — in American policy simulation models
127. Developing a geographic analysis of healthcare desert regions in rural America and evaluating the health outcome and expenditure consequences of specialist and hospital access deficits
128. Characterizing the wealth gradient in American preventive care utilization, cancer screening rates, and chronic disease management quality using panel data from nationally representative surveys
129. Investigating the effect of criminal justice involvement and incarceration on health insurance coverage, healthcare access, and chronic disease outcomes in American adult populations
130. Analyzing the economic consequences of the racial wealth gap for health insurance coverage, out-of-pocket spending burden, and lifetime healthcare expenditure in American households
131. Developing a cost-benefit analysis of social determinants of health screening and referral programs in American primary care settings for patients with housing, food, and transportation insecurities
132. Characterizing the relationship between immigration status and health insurance coverage, healthcare utilization, and financial barriers to care across American immigrant communities
133. Investigating the economic returns to community health center investment in underserved American communities in terms of preventable hospitalization reduction and emergency department diversion
134. Analyzing the health and economic consequences of Supplemental Security Income and Social Security Disability Insurance program eligibility decisions for American adults with disability applications
135. Developing an intergenerational economic model linking maternal health insurance coverage and care quality during pregnancy to offspring educational attainment and lifetime earnings in American populations
136. Characterizing the relationship between state Earned Income Tax Credit generosity and child health outcomes, healthcare utilization, and family healthcare expenditure in American low-income families
137. Investigating the economic returns to health equity investments in American public health programs targeting social determinants using return-on-investment modeling with long-term health outcome data
138. Analyzing the financial toxicity of cancer treatment in American households across insurance type, income level, and treatment intensity using linked claims and survey data
139. Developing a distributional cost-effectiveness analysis of COVID-19 vaccination program delivery strategies across American communities stratified by socioeconomic vulnerability and baseline vaccination rates
140. Characterizing the relationship between American neighborhood disinvestment, environmental health burden, and lifetime healthcare expenditure using linked environmental, census, and claims data

8. Long-Term Care and Aging Economics

The economics of long-term care and aging represents a rapidly growing priority as the American population over sixty-five expands dramatically — creating an urgent category of health economics thesis topics centered on nursing home markets, home and community-based services, Medicare and Medicaid financing of long-term care, informal caregiving, and the financial planning challenges facing American families confronting catastrophic long-term care costs. Graduate students contribute economic analyses of nursing home quality and competition, caregiver labor markets, long-term care insurance market failures, and the fiscal implications of population aging for American public programs.

141. Investigating the relationship between nursing home market competition and quality outcomes including staffing ratios, deficiency citations, and hospitalization rates in American Medicare and Medicaid certified facilities
142. Analyzing the impact of minimum staffing ratio regulations on nursing home quality, cost, and market exit decisions in American states that have implemented these requirements
143. Developing an economic model of the long-term care insurance market failure in America and evaluating public reinsurance, mandatory enrollment, and catastrophic coverage policy solutions
144. Characterizing the caregiver labor market wage dynamics and workforce shortage patterns in American home health and personal care aide sectors and their relationship to Medicaid reimbursement rates
145. Investigating the effect of Money Follows the Person program participation on nursing home to community transition rates and long-term care expenditure in American state Medicaid programs
146. Analyzing the relationship between for-profit nursing home ownership and private equity acquisition and quality of care, staffing levels, and financial performance in American long-term care markets
147. Developing a fiscal impact model for projecting Medicaid long-term care expenditure growth under different home and community-based services expansion scenarios in American state budgets
148. Characterizing the economic burden of informal caregiving on American family caregiver labor force participation, earnings, retirement savings, and long-term financial security
149. Investigating the impact of Medicare Advantage special needs plan enrollment on healthcare utilization, costs, and quality outcomes for American dual-eligible beneficiaries with complex care needs
150. Analyzing the relationship between Program of All-Inclusive Care for the Elderly participation and nursing home admission rates, healthcare costs, and quality of life in American frail elderly populations
151. Developing a discrete choice model of nursing home selection decisions by American families and identifying the quality, price, and location attributes that most influence facility choice
152. Characterizing the Medicaid spend-down asset depletion patterns and their economic consequences for American middle-income households facing catastrophic long-term care needs
153. Investigating the effectiveness of financial incentive structures in American value-based care programs for reducing avoidable hospitalizations among nursing home residents
154. Analyzing the relationship between American adult day service program availability and informal caregiver labor force participation rates and caregiver health outcomes
155. Developing a return on investment analysis of dementia caregiver support programs in American community settings for reducing caregiver burden and delaying nursing home placement
156. Characterizing the geographic access disparities in home and community-based service availability for American Medicaid beneficiaries with physical disabilities across rural and urban areas
157. Investigating the economic consequences of Alzheimer’s disease and related dementias for American family household wealth, retirement security, and inter-generational wealth transfer
158. Analyzing the nursing home market consolidation patterns and chain ownership effects on quality, staffing, and financial performance in American state long-term care markets
159. Developing a cost-effectiveness analysis of geriatric care management programs for reducing high-cost healthcare utilization among American Medicare beneficiaries with multiple chronic conditions
160. Characterizing the relationship between Medicare reimbursement rate adequacy for skilled nursing facility post-acute care and facility participation, patient access, and discharge planning practices

9. Global Health Economics

Global health economics applies economic analysis to health challenges in low- and middle-income countries, addressing aid effectiveness, health financing in resource-constrained settings, the economics of infectious disease control, and the trade-offs between competing health investments — making it a distinctive and increasingly prominent category of health economics thesis topics at American institutions with global health programs. Graduate students contribute economic evaluations of global health interventions, analyses of international health financing flows, and theoretical frameworks for priority-setting in settings where resource constraints are far more severe than in the American context.

161. Investigating the macroeconomic returns to malaria control investments in high-burden sub-Saharan African countries using instrumental variable approaches to address the endogeneity of health and economic growth
162. Analyzing the health financing transition economic challenges facing middle-income countries becoming ineligible for Global Fund and GAVI assistance and developing domestic resource mobilization strategies
163. Developing a cost-effectiveness analysis framework for evaluating community health worker program investments in low-income countries that accounts for system-strengthening co-benefits beyond targeted disease outcomes
164. Characterizing the catastrophic health expenditure burden and its determinants across income quintiles in low- and middle-income countries implementing different health financing arrangements
165. Investigating the optimal subsidy design for insecticide-treated bed net distribution in high malaria-burden African countries using randomized price variation experiments to estimate demand curves
166. Analyzing the economic consequences of tuberculosis on household income, productivity, and poverty in high-burden South Asian and African countries using matched case-control methodology
167. Developing a benefit-cost analysis of vaccine introduction decisions in low-income countries that incorporates both health outcome values and economic productivity and catastrophic expenditure avoidance benefits
168. Characterizing the supply-side constraints limiting health service utilization in low-income country rural settings beyond user fee and demand-side barriers using structural economic modeling
169. Investigating the fiscal space analysis methodology for projecting domestic health financing capacity expansion in low-income countries seeking to reduce dependence on official development assistance
170. Analyzing the economic evaluation evidence base quality for priority-setting in essential health benefit package design in low- and middle-income countries undergoing universal health coverage reform
171. Developing an economic model of antibiotic resistance spread that incorporates cross-country externalities and designs optimal international coordination mechanisms for stewardship incentive alignment
172. Characterizing the labor market and economic productivity consequences of HIV treatment scale-up on household income, savings, and investment in high-prevalence sub-Saharan African countries
173. Investigating the distributional effects of community-based health insurance implementation on financial protection and care utilization equity across income groups in low-income African countries
174. Analyzing the return on investment for neglected tropical disease control programs in terms of school attendance, cognitive development, and adult labor productivity in endemic low-income countries
175. Developing a cost-benefit framework for evaluating pandemic preparedness investment in low-income countries that incorporates the expected costs of future epidemic events and response capacity gaps
176. Characterizing the price and availability of essential medicines across public and private sector health facilities in low-income countries and evaluating the economic barriers to treatment access
177. Investigating the economic impact of climate-related agricultural shocks on household health expenditure, care-seeking behavior, and health outcomes in rain-fed farming communities in sub-Saharan Africa
178. Analyzing the trade policy and intellectual property provisions affecting pharmaceutical market access and pricing for essential medicines in low-income countries party to American-negotiated trade agreements
179. Developing an economic evaluation of health system strengthening program investments by American bilateral assistance programs using counterfactual modeling of health outcome improvements attributable to investment
180. Characterizing the economic returns to girls’ secondary education for maternal health outcomes, child mortality, and healthcare expenditure in low- and middle-income countries using instrumental variable approaches

10. Health Economics Methods and Data Infrastructure

The methodological foundations of health economics — causal inference, decision modeling, health utility measurement, cost measurement, and the data infrastructure supporting economic analysis — represent an important and evolving category of health economics thesis topics for students with strong quantitative interests and an orientation toward advancing the analytical toolkit of the discipline itself. Research here addresses the validity of natural experiment designs, the measurement of health-related quality of life, the appropriate perspective for cost analyses, and the development of novel data linkages that enable more credible health economic research. American graduate programs in health economics and health services research contribute methodological advances that improve the quality of evidence available for healthcare resource allocation decisions.

181. Investigating the validity of instrumental variable approaches using geographic distance to specialty care as an instrument for treatment intensity in American health economics causal inference studies
182. Analyzing the measurement properties and convergent validity of preference-based health utility instruments — including EQ-5D and SF-6D — across American patient populations with different chronic conditions
183. Developing a standardized healthcare cost measurement framework for American multi-payer environments that harmonizes cost perspectives across Medicare, Medicaid, commercial insurance, and out-of-pocket payment categories
184. Characterizing the regression discontinuity design validity assumptions and falsification test approaches in American health economics studies using Medicare eligibility age sixty-five as a threshold
185. Investigating the synthetic control method performance for evaluating American state-level health policy interventions with small numbers of treated units and limited pre-intervention comparison periods
186. Analyzing the all-payer claims database coverage, data quality, and research accessibility variation across American states and their implications for comparative health systems research
187. Developing a machine learning-assisted confounder selection methodology for propensity score analysis in American health economics observational studies using electronic health record and claims data
188. Characterizing the patient-reported outcome measure selection and scoring practices in American cost-effectiveness analyses and evaluating their sensitivity to utility elicitation methodology variation
189. Investigating the external validity limitations of American randomized controlled trial economic evaluation findings for informing coverage decisions in populations not represented in trial enrollment
190. Analyzing the linked Medicare-Medicaid administrative data infrastructure availability and access pathway barriers for American health economics researchers studying dual-eligible beneficiary populations
191. Developing a simulation study comparing the performance of difference-in-differences, interrupted time series, and synthetic control methods for evaluating American state health policy natural experiments
192. Characterizing the indirect cost measurement approaches used in American societal perspective cost-effectiveness analyses and evaluating the sensitivity of cost-per-QALY estimates to productivity loss valuation methodology
193. Investigating the willingness-to-pay threshold calibration approaches used by American health technology assessment organizations and evaluating their empirical and normative foundations
194. Analyzing the data linkage methodology and privacy governance frameworks enabling American Medicare claims to electronic health record research data integration for health economics studies
195. Developing a multi-attribute health utility instrument validation study in American elderly populations for whom existing preference-based measures may not adequately capture relevant health dimensions
196. Characterizing the publication bias patterns in American health economics cost-effectiveness literature and their implications for systematic review and meta-analysis of economic evidence
197. Investigating the causal inference validity of interrupted time series designs for evaluating American hospital and health system policy changes using simulation studies with varying pre-intervention data lengths
198. Analyzing the Medicare Current Beneficiary Survey data quality and representativeness for American health economics research on Medicare program costs, utilization, and beneficiary financial burden
199. Developing a federated data analysis framework for enabling multistate all-payer claims database research without individual-level data transfer to address American health economics research governance barriers
200. Characterizing the economic modeling transparency and reproducibility standards in published American health technology assessment submissions and developing recommendations for reporting guideline enhancement

The Range of Health Economics Thesis Topics

Current Issues

Healthcare affordability has reached a crisis point for millions of Americans, as premium growth, high-deductible plan proliferation, and rising out-of-pocket costs for prescription drugs and specialty care push healthcare expenses beyond what many middle-income families can sustain. Medical debt has become the leading cause of personal bankruptcy in the United States, and evidence is accumulating that cost-related care avoidance — skipping medications, delaying needed procedures, and forgoing preventive services — is translating into worse health outcomes and ultimately higher long-term healthcare expenditures. Health economics thesis topics that rigorously measure the welfare consequences of healthcare cost burdens, evaluate the effectiveness of cost-sharing design reforms, and model the long-term health and economic effects of care avoidance are addressing the most immediate financial reality facing American households across the income distribution.

Pharmaceutical pricing has emerged as perhaps the most politically activated domain within health economics, as the United States continues to pay dramatically higher prices for brand-name drugs than peer nations while pharmaceutical companies defend these prices as essential for financing research and development investment. The Inflation Reduction Act’s authorization of Medicare drug price negotiation for a limited number of high-expenditure medications represents a watershed policy development that is generating important natural experiment opportunities for health economics research — allowing researchers to evaluate the effects of negotiated prices on access, utilization, launch pricing behavior for new drugs, and research and development investment patterns. Graduate students developing health economics thesis topics in pharmaceutical economics are positioned at the center of one of the most consequential and contested policy debates in American healthcare.

The consolidation of American hospital and physician markets has continued at a rapid pace, concentrating market power in ways that antitrust enforcement has struggled to prevent and that economic research consistently links to higher prices and, in some analyses, lower quality for commercially insured patients. The Federal Trade Commission has become more aggressive in challenging both horizontal and vertical mergers in healthcare, creating a productive tension between market consolidation trends and regulatory resistance that is generating important research questions about competitive market definition, the efficiencies that may justify consolidation, and the distributional consequences of market power for different patient populations. Health economics thesis topics examining these dynamics contribute directly to the empirical evidence base that regulators, courts, and policymakers rely on to make consequential decisions about American healthcare market structure.

Recent Trends

Value-based payment reform has matured from an experimental innovation into a central feature of American healthcare financing, with accountable care organizations, bundled payment programs, and alternative payment models now covering substantial shares of Medicare and commercial insurance spending. The research evidence on whether these payment reforms are achieving their goals of improving quality while reducing cost growth has become more nuanced and sometimes disappointing — with some analyses finding meaningful savings and quality improvements and others finding minimal effects — creating important questions about which design features, market conditions, and implementation characteristics determine payment reform success. Health economics thesis topics that move beyond simple program evaluations toward understanding the mechanisms and moderators of payment reform effects are generating the more actionable policy insights that the field needs.

The application of machine learning and big data methods to health economics research has dramatically expanded the analytical possibilities available to graduate students, enabling more sophisticated causal inference approaches, richer characterization of heterogeneous treatment effects, and the discovery of patterns in large administrative datasets that traditional econometric methods would miss. American researchers are increasingly using electronic health record data, all-payer claims databases, and linked administrative datasets to answer health economics questions with greater statistical precision and external validity than was previously possible. Health economics thesis topics that develop and apply these methodological innovations while maintaining rigorous attention to identification strategy validity and interpretive caution are advancing both the methodological frontier and the substantive knowledge base of the field.

Future Directions

The economics of artificial intelligence in healthcare will become an increasingly important domain of health economics thesis topics as AI-enabled diagnostics, clinical decision support, and administrative automation tools are deployed at scale across American healthcare systems. Economic analysis is needed to evaluate whether these technologies deliver value relative to their costs, how their benefits and risks are distributed across patient populations, and what market structures and regulatory frameworks are needed to ensure that AI investment serves health system goals rather than simply generating returns for technology vendors. Future health economics research will develop the cost-effectiveness frameworks, market analysis tools, and distributional assessment methodologies needed to guide American healthcare AI investment toward applications that genuinely improve value and equity.

The long-term fiscal sustainability of Medicare and Medicaid — programs that together cover nearly half of all Americans and account for a growing share of federal and state budgets — will remain the defining macroeconomic challenge shaping American health economics research for the coming generation. Future health economics thesis topics will develop more sophisticated models of healthcare spending growth drivers, evaluate the effectiveness of cost-containment mechanisms from premium support to global budgets to drug price regulation, and investigate the distributional consequences of different fiscal adjustment strategies for the beneficiary populations most dependent on these programs. As the baby boom generation ages fully into Medicare and as Medicaid continues its role as the primary safety net for Americans with low incomes and disabilities, the economic analysis of these programs becomes ever more consequential for the health and financial security of the American population.

Conclusion

The 200 health economics thesis topics presented across these ten categories reflect the analytical breadth and policy urgency of a discipline that addresses insurance market design, hospital competition, pharmaceutical pricing, behavioral economics, cost-effectiveness analysis, long-term care financing, global health investment, and the methodological foundations of economic evidence in healthcare. Students pursuing health economics thesis topics at American universities engage with research questions that directly shape legislation, regulatory policy, coverage decisions, and the organization of care — with career pathways extending into academic economics and health policy, federal and state government agencies, health insurance and pharmaceutical industries, management consulting, and international development organizations. The discipline’s commitment to rigorous causal inference and welfare-relevant policy analysis ensures that contributions in this field have lasting value for the Americans and global populations whose health and financial security depend on well-functioning healthcare systems.

Academic Support

iResearchNet provides expert academic support for graduate students developing health economics thesis topics across the full range of this discipline’s methodological and substantive domains. Our consultants bring specialized expertise in health insurance economics, provider payment reform, pharmaceutical market analysis, cost-effectiveness modeling, health behavior economics, hospital market structure, long-term care financing, and health economics research methods — with direct experience supporting students in American economics departments, schools of public health, and health policy programs. Whether you are refining a causal identification strategy, building a decision analytic model, analyzing complex administrative claims data, or developing a theoretical framework for a health market phenomenon, iResearchNet’s support is oriented toward strengthening your scholarly development and deepening your engagement with health economics as a discipline. Our mission is to support your intellectual growth as a researcher, not to substitute for the original thinking and analytical rigor that define excellent graduate scholarship in health economics.